Dear Readers, Pharma Industrial India Magazine is happy to share its latest work i.e November-December 2024 issue with you. The issue brings standalone thought leadership from: Ashish Moghe, Managing Director, Nipro PharmaPackaging India; Gabriella Kiss, Ph.D., Director-Regulatory Strategy and Engagement, Refeyn; Ankita Mittal, CEO, Enhanced Innovations; Will Staddon, Global Head of Bulk Shipping Solutions, Peli BioThermal; Dr. Molly Weaver and Paul Rutter, Sr. VP-Clinical Affairs, ApiJect Systems Cover Story: Sadiq Khan, Managing Director, Bürkert Fluid Control Systems The issue also offers insight into various sectors through thought pieces from various industry pioneers and accelerators: Sumit Mehetre🌐, Marketing Manager, Sudeep Pharma; Manoj Kochar, President, ASPA We hope you enjoy our work!!! #biotech #india #healthcare #manufacturing #drugsanddevelopment #equipment #treatment #biotechnology #globalpharma #pharmaceuticals #PharmaIndustialIndia
Pharma Industrial India
Media Production
Pune, Maharashtra 5,877 followers
PROFESSIONAL MAGAZINE FOR PHARMA INDUSTRY SUPPLIERS AND LAB TECHNOLOGY
About us
PHARMA INDUSTRIAL INDIA is published by Omnimedia Publications India Pvt. Ltd. A 100% subsidiary of the European Omnimedia Group an International Publishing Company with leading technical magazines in the Energy, Construction, Tourism, Pharma and Life Sciences Industries, headquartered in Madrid, Spain. International Magazine for Pharmaceutical Industry Suppliers and Lab Technology. The Indian Pharma Industry expands rapidly and is already one of the largest pharmaceutical producers worldwide. This huge market requires technical equipment and services to compete in any phase of the pharmaceutical development, from the research stage to the final product.
- Website
-
http://www.pharmaindustrial-india.com/
External link for Pharma Industrial India
- Industry
- Media Production
- Company size
- 51-200 employees
- Headquarters
- Pune, Maharashtra
- Founded
- 2009
- Specialties
- Pharma Industry Magazine and Pharma Industrial India
Updates
-
Verismo Therapeutics has announced the completion of a merger in which the company has become a wholly-owned subsidiary of HLB Innovation, a publicly traded company in South Korea and a member of the HLB Group. Bryan Kim #healthcare #PharmaIndustrialIndia
-
Vanda Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation for VGT-1849A, a selective antisense oligonucleotide (ASO)-based JAK2 inhibitor for the treatment of polycythemia vera (PV), a form of a rare hematologic malignancy that is estimated to affect 1 in 2000 Americans.1 #healthcare #PharmaIndustrialIndia
Vanda Pharmaceuticals Receives Orphan Drug Designation Granted for VGT-1849A - Global Pharma
pharmaindustrial-india.com
-
Aadi Bioscience, Inc has entered into an exclusive #licenseagreement for development and global commercialization of a three-asset portfolio of preclinical, next-wave antibody-drug conjugates (ADCs), in collaboration with WuXi Biologics (2269.HK) and Hangzhou DAC Biotech Co., Ltd. (HANGZHOU DAC). Dave Lennon #healthcare #PharmaIndustrialIndia
Aadi Bioscience Signs Licensing Deal with WUXI and HANGZHOU DAC for Novel ADC Portfolio - Drug Discovery & Development
pharmaindustrial-india.com
-
LSPedia has announced the unveiling of its new office in Hyderabad, India, in January 2025. Riya Cao #healthcare #PharmaIndustrialIndia
LSPedia to Expand Globally with New Office Launch in India in January 2025 - Global Pharma
pharmaindustrial-india.com
-
Our ISO-accredited thermal labs enable us to replicate varying #environmentalconditions for pre-qualified testing, ensuring our products are fully compliant and ready for real-world conditions, states Will Staddon, Head-Key Accounts and Partnerships for Bulk Solutions, Peli BioThermal in his interaction with Aishwarya Saxena, Pharma Industrial India. #healthcare #PharmaIndustrialIndia
Peli BioThermal Ensures Safety and Efficacy in Cold Chain Logistics - Interviews
pharmaindustrial-india.com
-
Juncell Therapeutics Co. Ltd., a biotech company, has opened a new #manufacturingfacility in the Anting International Medical Industry Park in Jiading District, Shanghai, China. #healthcare #manufacturing #PharmaIndustrialIndia
Juncell Therapeutics Opens New Manufacturing Facility in China - Manufacturing
pharmaindustrial-india.com
-
Hemogenyx Pharmaceuticals and Kure Pharmaceuticals Llc announce a strategic collaboration to advance the production of CAR-T #celltherapies for acute myeloid leukemia (AML) and a subset of acute lymphoblastic leukemia (ALL). Vladislav Sandler David Wald #healthcare #PharmaIndustrialIndia
Hemogenyx and Kure.ai Partner to Advance Production of CAR-T Cell Therapies - Manufacturing
pharmaindustrial-india.com
-
Lonza, a global #manufacturing partner to the #pharmaceutical, #biotech and nutraceutical markets, announced capacity expansions at its sites in Rewari (India) and Suzhou (China). Aanchal Tomar #healthcare #PharmaIndustrialIndia
Lonza Announces Capacity Expansions at its Sites in India and China - Manufacturing
pharmaindustrial-india.com
-
Alembic Pharmaceuticals Limited (Alembic) has announced that it has received final approval from the US Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) Divalproex Sodium Delayed-Release Capsules USP, 125 mg. #healthcare #PharmaIndustrialIndia
Alembic Pharmaceuticals Gets USFDA Final Approval for Divalproex Sodium Delayed-Release Capsules USP, 125 mg - Global Pharma
pharmaindustrial-india.com